Screener
Acadia Pharmaceuticals ACAD Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | (29,188) | (8,766) |
| Interest and other receivables | 11,080 | (6,225) |
| Inventory | 3,975 | (14,553) |
| Prepaid expenses and other current assets | (9,843) | 2,934 |
| Other assets | 346 | (1,306) |
| Operating lease right-of-use assets | 4,398 | 4,259 |
| Accounts payable | 33,666 | 3,905 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Acadia Pharmaceuticals's inventories?
- Acadia Pharmaceuticals (ACAD) reported inventories of -$3.9M in Q2 2026.
- How has Acadia Pharmaceuticals's inventories changed year-over-year?
- Acadia Pharmaceuticals's inventories decreased by 195.0% year-over-year, from $4.1M to -$3.9M.
- What is the long-term trend for Acadia Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's inventories has grown at a -12.8% compound annual growth rate (CAGR), from $9.68M to $4.89M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Acadia Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude